884.25 -0.05 (-0.01%)

43.29% Fall from 52W High

451.5K NSE+BSE Volume

NSE 19 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Classification
Natco Pharma's Hyderabad facility gets US FDA's voluntary action indicated (VAI) classification See details


Natco Pharma Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for NATCOPHARM, BSE:524816 Natco Pharma Ltd.

567 Votes:
Buy 83.25%
Sell 7.41%
Hold 9.35%
BUY
SELL
HOLD